Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1997-1-27
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0006-4971
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
89
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
345-6
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:8978311-Acute Disease,
pubmed-meshheading:8978311-Antigens, Differentiation,
pubmed-meshheading:8978311-Antigens, Neoplasm,
pubmed-meshheading:8978311-Humans,
pubmed-meshheading:8978311-Incidence,
pubmed-meshheading:8978311-Leukemia, Myeloid,
pubmed-meshheading:8978311-Leukemia, Myeloid, Acute,
pubmed-meshheading:8978311-Tumor Markers, Biological
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Biological pattern of AML-M0 versus AML-M1: response.
|
| pubmed:publicationType |
Letter,
Comment
|